Literature DB >> 22112679

Bone mineral density and all-cause, cardiovascular and stroke mortality: a meta-analysis of prospective cohort studies.

Xinhua Qu1, Xiaolu Huang, Fangchun Jin, Hao Wang, Yongqiang Hao, Tingting Tang, Kerong Dai.   

Abstract

BACKGROUND: Low bone mineral density (BMD) has been associated with increased mortality in prospective cohort studies of the elderly, but the real relationship is still controversial. We undertook a meta-analysis to evaluate the association of BMD with risk of all-cause, cardiovascular and stroke mortality.
METHODS: We performed systematic searches on MEDLINE, EMBASE, OVID, CINAHL, and the Cochrane Library. Data extraction was performed independently by two reviewers. For each study, hazard ratios (HRs) and 95% confidence intervals (CI) per standard deviation (SD) decrease in BMD were extracted. Heterogeneity, publication bias, subgroup, and meta-regression analysis were performed.
RESULTS: The analysis included 46,182 participants from 10 studies with 3991 all-cause deaths, 1479 cardiovascular deaths and 403 stroke deaths during a median of 7 years follow-up (range 2.8-18.7 years). Lower BMD had a significant inverse relationship with all-cause and cardiovascular mortality, a per SD decrease in BMD at all sites being associated with a 1.17-fold (95% CI: 1.13-1.22) increase in total mortality and a 1.13-fold increase in cardiovascular mortality (95% CI: 1.06-1.20). Lower total hip/femoral neck BMD was also related to all-cause mortality (HR 1.20; 95% CI: 1.09-1.31) and cardiovascular mortality (HR 1.20; 95% CI: 1.04-1.35). BMD was not associated with the risk of stroke mortality (HR 1.08, 95% CI; 0.89-1.28).
CONCLUSIONS: Lower BMD is associated with significantly increased risk of all-cause and cardiovascular mortality. There is no significant association between lower BMD and the risk of stroke mortality. The relationship between lower BMD and individual mortality should be investigated further in randomized trials.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22112679     DOI: 10.1016/j.ijcard.2011.10.114

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  32 in total

1.  Relationship between bone cross-sectional area and indices of peripheral artery disease.

Authors:  Claudio Pedone; Simone Scarlata; Nicola Napoli; Fulvio Lauretani; Stefania Bandinelli; Luigi Ferrucci; Raffaele Antonelli Incalzi
Journal:  Calcif Tissue Int       Date:  2013-09-01       Impact factor: 4.333

2.  Volumetric bone mineral density of the spine predicts mortality in African-American men with type 2 diabetes.

Authors:  L Lenchik; T C Register; G B Russell; J Xu; S C Smith; D W Bowden; J Divers; B I Freedman
Journal:  Osteoporos Int       Date:  2018-05-31       Impact factor: 4.507

3.  Nonlinear association between bone mineral density and all-cause mortality: the Dong-gu study.

Authors:  C K Choi; S -S Kweon; Y -H Lee; H -S Nam; K -S Park; S -Y Ryu; S -W Choi; S A Kim; M -H Shin
Journal:  Osteoporos Int       Date:  2018-07-16       Impact factor: 4.507

4.  Proximal Femur Volumetric Bone Mineral Density and Mortality: 13 Years of Follow-Up of the AGES-Reykjavik Study.

Authors:  Elisa A Marques; Martine Elbejjani; Vilmundur Gudnason; Gunnar Sigurdsson; Thomas Lang; Sigurdur Sigurdsson; Thor Aspelund; Osorio Meirelles; Kristin Siggeirsdottir; Lenore Launer; Gudny Eiriksdottir; Tamara B Harris
Journal:  J Bone Miner Res       Date:  2017-03-20       Impact factor: 6.741

5.  The relation of low levels of bone mineral density with coronary artery calcium and mortality.

Authors:  N Ahmadi; S S Mao; F Hajsadeghi; B Arnold; S Kiramijyan; Y Gao; F Flores; S Azen; M Budoff
Journal:  Osteoporos Int       Date:  2018-04-27       Impact factor: 4.507

6.  Bone Mineral Density of the Radius Predicts All-Cause Mortality in Patients With Type 2 Diabetes: Diabetes Heart Study.

Authors:  Leon Lenchik; Thomas C Register; Fang-Chi Hsu; Jianzhao Xu; S Carrie Smith; J Jeffrey Carr; Barry I Freedman; Donald W Bowden
Journal:  J Clin Densitom       Date:  2017-12-01       Impact factor: 2.617

7.  Young patients and those with a low eGFR benefitted more from denosumab therapy in femoral neck bone mineral density.

Authors:  Ben-Chung Cheng; Ying-Chou Chen
Journal:  Clin Rheumatol       Date:  2016-10-18       Impact factor: 2.980

8.  Association between loop diuretic use and fracture risk.

Authors:  F Xiao; X Qu; Z Zhai; C Jiang; H Li; X Liu; Z Ouyang; D Gu
Journal:  Osteoporos Int       Date:  2014-12-10       Impact factor: 4.507

Review 9.  Fracture mortality: associations with epidemiology and osteoporosis treatment.

Authors:  Sebastian E Sattui; Kenneth G Saag
Journal:  Nat Rev Endocrinol       Date:  2014-08-05       Impact factor: 43.330

10.  Coffee, tea, and the risk of hip fracture: a meta-analysis.

Authors:  J Sheng; X Qu; X Zhang; Z Zhai; H Li; X Liu; H Li; G Liu; Z Zhu; Y Hao; A Qin; K Dai
Journal:  Osteoporos Int       Date:  2013-11-06       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.